Advances in the diagnosis of leukoencephalopathies

Bibliography

• Kim JH, Kim HJ. Childhood X-linked adrenoleukodystrophy: clinical-pathologic overview and MR imaging manifestations at initial evaluation and follow-up. Radiographics 2005;25:619-31
   PubMed Web of Science ®Google Scholar
• Farina L, Bizzi A, Finocchiaro G, MR imaging and proton MR spectroscopy in adult Krabbe disease. AJNR Am J Neuroradiol 2000;21:1478-82
   PubMed Web of Science ®Google Scholar
• Naidu S, Bibat G, Lin D, Progressive cavitating leukoencephalopathy: a novel childhood disease. Ann Neurol 2005;58:929-38
   PubMed Web of Science ®Google Scholar
• Pronk JC, van KB Vanishing white matter disease: a review with focus on its genetics. Ment Retard Dev Disabil Res Rev 2006;12:123-8
   PubMedGoogle Scholar
• Haas RH, Parikh S, Falk MJ, Mitochondrial disease: a practical approach for primary care physicians. Pediatrics 2007;120:1326-33
   PubMed Web of Science ®Google Scholar
• Neilson DE, Adams MD, Orr CM, Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2. Am J Hum Genet 2009;84:44-51
   PubMed Web of Science ®Google Scholar
• Erikson A, Aula N, Aula P, Mansson JE. Free sialic acid storage (Salla) disease in Sweden. Acta Paediatr 2002;91:1324-7
   PubMed Web of Science ®Google Scholar
• Gorospe JR, Singhal BS, Kainu T, Indian Agarwal megalencephalic leukodystrophy with cysts is caused by a common MLC1 mutation. Neurology 2004;62:878-82
   PubMed Web of Science ®Google Scholar
• Madry H, Prudlo J, Grgic A, Freyschmidt J. Nasu-Hakola disease (PLOSL): report of five cases and review of the literature. Clin Orthop Relat Res 2007;454:262-9
   PubMedGoogle Scholar
• Adams D, Gahl WA. Free Sialic Acid Storage Disorders. University of Washington; Seattle: 2008
   Google Scholar
• Steinberg SJ, Dodt G, Raymond GV, Peroxisome biogenesis disorders. Biochim Biophys Acta 2006;1763:1733-48
   PubMed Web of Science ®Google Scholar
• Kurotaki N, Imaizumi K, Harada N, Haploinsufficiency of NSD1 causes Sotos syndrome. Nat Genet 2002;30:365-6
   PubMed Web of Science ®Google Scholar
• Paznekas WA, Boyadjiev SA, Shapiro RE, Connexin 43 (GJA1) mutations cause the pleiotropic phenotype of oculodentodigital dysplasia. Am J Hum Genet 2003;72:408-18
   PubMed Web of Science ®Google Scholar
• Saito Y, Masuko K, Kaneko K, Brain MRI findings of older patients with Pallister-Killian syndrome. Brain Dev 2006;28:34-8
   PubMed Web of Science ®Google Scholar
• Zara F, Biancheri R, Bruno C, Bordo L. Deficiency of hyccin, a newly identified membrane protein, causes hypomyelination and congenital cataract. Nat Genet 2006;38:1111-13
   PubMed Web of Science ®Google Scholar
• van der Knaap MS, Naidu S, Pouwels PJ, New syndrome characterized by hypomyelination with atrophy of the basal ganglia and cerebellum. AJNR Am J Neuroradiol 2002;23:1466-74
   PubMed Web of Science ®Google Scholar
• Bernard G, Chouery E, Putorti ML, Mutations of POLR3A encoding a catalytic subunit of RNA polymerase Pol III cause a recessive hypomyelinating leukodystrophy. Am J Hum Genet 2011;89(3):415-23
   PubMed Web of Science ®Google Scholar
• Saitsu H, Osaka H, Sasaki M, Mutations in POLR3A and POLR3B encoding RNA Polymerase III subunits cause an autosomal-recessive hypomyelinating leukoencephalopathy. Am J Hum Genet 2011;89(5):644-51
   PubMed Web of Science ®Google Scholar
• Naidu S, Hofmann KJ, Moser HW, Galactosylceramide-beta-galactosidase deficiency in association with cherry red spot. Neuropediatrics 1988;19:46-8
   PubMed Web of Science ®Google Scholar
• Meijer IA, Simoes-Lopes AA, Laurent S, A novel duplication confirms the involvement of 5q23.2 in autosomal dominant leukodystrophy. Arch Neurol 2008;65:1496-501
   PubMed Web of Science ®Google Scholar
• Ramakrishnan H, Hedayati KK, Lullmann-Rauch R, Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy. J Neurosci 2007;27:9482-90
   PubMed Web of Science ®Google Scholar
• Goebel HH. Extracerebral biopsies in neurodegenerative diseases of childhood. Brain Dev 1999;21:435-43
   PubMed Web of Science ®Google Scholar
• Shy ME, Hobson G, Jain M, Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy. Ann Neurol 2003;53:354-65
   PubMed Web of Science ®Google Scholar
• Uhlenberg B, Schuelke M, Ruschendorf F, Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease. Am J Hum Genet 2004;75:251-60
   PubMed Web of Science ®Google Scholar
• Marti R, Spinazzola A, Nishino I, Mitochondrial neurogastrointestinal encephalomyopathy and thymidine metabolism: results and hypotheses. Mitochondrion 2002;2:143-7
   PubMed Web of Science ®Google Scholar
• Austin JH. Metachromatic form of diffuse cerebral sclerosis. I. Diagnosis during life by urine sediment examination. Neurology 1957;7:415-26
   PubMed Web of Science ®Google Scholar
• Austin J, McAfee D, Armstrong D, Low sulfatase activities in metachromatic leukodystrophy (MLD). A controlled study of enzymes in 9 living and 4 autopsied patients with MLD. Trans Am Neurol Assoc 1964;89:147-50
   PubMedGoogle Scholar
• Gieselmann V, von FK. Advances in the molecular genetics of metachromatic leukodystrophy. J Inherit Metab Dis 1990;13:560-71
   PubMed Web of Science ®Google Scholar
• Sevin C, Cartier-Lacave N, Aubourg P. Gene therapy in metachromatic leukodystrophy. Int J Clin Pharmacol Ther 2009;47(Suppl 1):S128-31
   PubMedGoogle Scholar
• Weimer JM, Kriscenski-Perry E, Elshatory Y, Pearce DA. The neuronal ceroid lipofuscinoses: mutations in different proteins result in similar disease. Neuromolecular Med 2002;1:111-24
   PubMed Web of Science ®Google Scholar
• Husain S, Marsh E, Saenz-Santamaria MC, McNutt NS. Hermansky-Pudlak syndrome: report of a case with histological, immunohistochemical and ultrastructural findings. J Cutan Pathol 1998;25:380-5
   PubMed Web of Science ®Google Scholar
• Malandrini A, Gaudiano C, Gambelli S, Diagnostic value of ultrastructural skin biopsy studies in CADASIL. Neurology 2007;68:1430-2
   PubMed Web of Science ®Google Scholar
• Plaisier E, Gribouval O, Alamowitch S, COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. N Engl J Med 2007;357:2687-95
   PubMed Web of Science ®Google Scholar
• Sommer C. Skin biopsy as a diagnostic tool. Curr Opin Neurol 2008;21:563-8
   PubMed Web of Science ®Google Scholar
• Robitaille Y, Carpenter S, Karpati G, DiMauro SD. A distinct form of adult polyglucosan body disease with massive involvement of central and peripheral neuronal processes and astrocytes: a report of four cases and a review of the occurrence of polyglucosan bodies in other conditions such as Lafora's disease and normal ageing. Brain 1980;103:315-36
   PubMed Web of Science ®Google Scholar
• Khateeb S, Flusser H, Ofir R, PLA2G6 mutation underlies infantile neuroaxonal dystrophy. Am J Hum Genet 2006;79:942-8
   PubMed Web of Science ®Google Scholar
• Menkes JH. Chemical studies of two cerebral biopsies in juvenile metachromatic leukodystrophy: the molecular composition of cerebrosides and sulfatides. J Pediatr 1966;69:422-31
   PubMed Web of Science ®Google Scholar
• MacGregor DL, Humphrey RP, Armstrong DL, Becker LE. Brain biopsies for neurodegenerative disease in children. J Pediatr 1978;92:903-5
   PubMed Web of Science ®Google Scholar
• Garbern JY, Hobson GM. PLP-1 related disorders. Gene Rev (Internet) 1993; published online; doi:NBK1182; bookaccession
   Google Scholar
• Garbern JY, Cambi F, Lewis R, Peripheral neuropathy caused by proteolipid protein gene mutations. Ann NY Acad Sci 1999;883:351-65
   PubMed Web of Science ®Google Scholar
• van der Knaap MS, Naidu S, Kleinschmidt-Demasters BK, Autosomal dominant diffuse leukoencephalopathy with neuroaxonal spheroids. Neurology 2000;54:463-8
   PubMed Web of Science ®Google Scholar
• Crow YJ, Leitch A, Hayward BE, Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutieres syndrome and mimic congenital viral brain infection. Nat Genet 2006;38:910-16
   PubMed Web of Science ®Google Scholar
• Crow YJ, Hayward BE, Parmar R, Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus. Nat Genet 2006;38:917-20
   PubMed Web of Science ®Google Scholar
• Rice GI, Bond J, Asipu A, Mutations involved in Aicardi-Goutieres syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet 2009;41:829-32
   PubMed Web of Science ®Google Scholar
• Izzotti A, Pulliero A, Orcesi S, Interferon-related transcriptome alterations in the cerebrospinal fluid cells of Aicardi-Goutieres patients. Brain Pathol 2009;19:650-60
   PubMed Web of Science ®Google Scholar
• Mochel F, Yang B, Barritault J, Free sialic acid storage disease without sialuria. Ann Neurol 2009;65:753-7
   PubMed Web of Science ®Google Scholar
• Mochel F, Sedel F, Vanderver A, Cerebellar ataxia with elevated cerebrospinal free sialic acid (CAFSA). Brain 2009;132:801-9
   PubMed Web of Science ®Google Scholar
• Rafi MA, Coppola S, Liu SL, Disease-causing mutations in cis with the common arylsulfatase A pseudodeficiency allele compound the difficulties in accurately identifying patients and carriers of metachromatic leukodystrophy. Mol Genet Metab 2003;79:83-90
   PubMed Web of Science ®Google Scholar
• Deconinck N, Messaaoui A, Ziereisen F, Metachromatic leukodystrophy without arylsulfatase A deficiency: a new case of saposin-B deficiency. Eur J Paediatr Neurol 2008;12:46-50
   PubMed Web of Science ®Google Scholar
• Rodenburg RJ. Biochemical diagnosis of mitochondrial disorders. J Inherit Metab Dis 2010; published online; doi:10.1007/s10545-010-9081-y; doi
   Web of Science ®Google Scholar
• Scheper GC, van der Klok T, van Andel RJ, Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat Genet 2007;39:534-9
   PubMed Web of Science ®Google Scholar
• Verheijen FW, Verbeek E, Aula N, A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases. Nat Genet 1999;23:462-5
   PubMed Web of Science ®Google Scholar
• Sonninen P, Autti T, Varho T, Brain involvement in Salla disease. AJNR Am J Neuroradiol 1999;20:433-43
   PubMed Web of Science ®Google Scholar
• de Sain-van der Velden MG, Verrips A, Prinsen BH, Elevated cholesterol precursors other than cholestanol can also be a hallmark for CTX. J Inherit Metab Dis 2008; published online; doi:10.1007/s10545-008-0963-1; doi
   PubMed Web of Science ®Google Scholar
• Gallus GN, Dotti MT, Federico A. Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene. Neurol Sci 2006;27:143-9
   PubMed Web of Science ®Google Scholar
• Hofmann SL, Atashband A, Cho SK, Neuronal ceroid lipofuscinoses caused by defects in soluble lysosomal enzymes (CLN1 and CLN2). Curr Mol Med 2002;2:423-37
   PubMedGoogle Scholar
• Vanhanen SL, Puranen J, Autti T, Neuroradiological findings (MRS, MRI, SPECT) in infantile neuronal ceroid-lipofuscinosis (infantile CLN1) at different stages of the disease. Neuropediatrics 2004;35:27-35
   PubMed Web of Science ®Google Scholar
• Vanhanen SL, Raininko R, Autti T, Santavuori P. MRI evaluation of the brain in infantile neuronal ceroid-lipofuscinosis. Part 2: MRI findings in 21 patients. J Child Neurol 1995;10:444-50
   PubMed Web of Science ®Google Scholar
• Rzem R, Veiga-da-Cunha M, Noel G, A gene encoding a putative FAD-dependent L-2-hydroxyglutarate dehydrogenase is mutated in L-2-hydroxyglutaric aciduria. Proc Natl Acad Sci USA 2004;101:16849-54
   PubMed Web of Science ®Google Scholar
• Topcu M, Jobard F, Halliez S, L-2-Hydroxyglutaric aciduria: identification of a mutant gene C14orf160, localized on chromosome 14q22.1. Hum Mol Genet 2004;13:2803-11
   PubMed Web of Science ®Google Scholar
• Moroni I, Bugiani M, D'Incerti L, L-2-hydroxyglutaric aciduria and brain malignant tumors: a predisposing condition? Neurology 2004;62:1882-4
   PubMed Web of Science ®Google Scholar
• van der Knaap MS, Lai V, Kohler W, Megalencephalic leukoencephalopathy with cysts without MLC1 defect. Ann Neurol 2010;67:834-7
   PubMed Web of Science ®Google Scholar
• Fogli A, Wong K, Eymard-Pierre E, Cree leukoencephalopathy and CACH/VWM disease are allelic at the EIF2B5 locus. Ann Neurol 2002;52:506-10
   PubMed Web of Science ®Google Scholar
• Crow YJ, Black DN, Ali M, Cree encephalitis is allelic with Aicardi-Goutieres syndrome: implications for the pathogenesis of disorders of interferon alpha metabolism. J Med Genet 2003;40:183-7
   PubMed Web of Science ®Google Scholar
• Crow YJ, Rehwinkel J. Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. Hum Mol Genet 2009;18:R130-6
   PubMed Web of Science ®Google Scholar
• Kolivras A, Aeby A, Crow YJ, Cutaneous histopathological findings of Aicardi-Goutieres syndrome, overlap with chilblain lupus. J Cutan Pathol 2008;35:774-8
   PubMed Web of Science ®Google Scholar
• Crow YJ. Type I interferonopathies: a novel set of inborn errors of immunity. Ann NY Acad Sci 2011;1238:91-8
   PubMed Web of Science ®Google Scholar
• Henneke M, Diekmann S, Ohlenbusch A, RNASET2-deficient cystic leukoencephalopathy resembles congenital cytomegalovirus brain infection. Nat Genet 2009;41:773-5
   PubMed Web of Science ®Google Scholar
• Leegwater PA, Yuan BQ, van der Steen J, Mutations of MLC1 (KIAA0027), encoding a putative membrane protein, cause megalencephalic leukoencephalopathy with subcortical cysts. Am J Hum Genet 2001;68:831-8
   PubMed Web of Science ®Google Scholar
• Leegwater PA, Vermeulen G, Konst AA, Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. Nat Genet 2001;29:383-8
   PubMed Web of Science ®Google Scholar
• Wolf NI, Harting I, Boltshauser E, Leukoencephalopathy with ataxia, hypodontia, and hypomyelination. Neurology 2005;64:1461-4
   PubMed Web of Science ®Google Scholar
• Lin J, Chiconelli FE, Da Rocha AJ, Leukoencephalopathy with brainstem and spinal cord involvement and normal lactate: a new mutation in the DARS2 gene. J Child Neurol 2010;25:1425-8
   PubMed Web of Science ®Google Scholar
• Gaudiano C, Malandrini A, Pollazzon M, Leukoencephalopathy in 21-beta hydroxylase deficiency: report of a family. Brain Dev 2010;32:421-4
   PubMed Web of Science ®Google Scholar
• Vaurs-Barriere C, Deville M, Sarret C, Pelizaeus-Merzbacher-Like disease presentation of MCT8 mutated male subjects. Ann Neurol 2009;65:114-18
   PubMed Web of Science ®Google Scholar
• Schiffmann R, van der Knaap MS. Invited article: an MRI-based approach to the diagnosis of white matter disorders. Neurology 2009;72:750-9
   PubMed Web of Science ®Google Scholar
• van der Knaap MS, Breiter SN, Naidu S, Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach. Radiology 1999;213:121-33
   PubMed Web of Science ®Google Scholar
• Steenweg ME, Vanderver A, Blaser S, Magnetic resonance imaging pattern recognition in hypomyelinating disorders. Brain 2010;133:2971-82
   PubMed Web of Science ®Google Scholar
• Schneck L, Adachi M, Volk BW. Congenital failure of myelinization: pelizaeus-Merzbacher disease? Neurology 1971;21:817-24
   PubMed Web of Science ®Google Scholar
• Haataja L, Parkkola R, Sonninen P, Phenotypic variation and magnetic resonance imaging (MRI) in Salla disease, a free sialic acid storage disorder. Neuropediatrics 1994;25:238-44
   PubMed Web of Science ®Google Scholar
• Schiffmann R, Dwyer NK, Lubensky IA, Constitutive achlorhydria in mucolipidosis type IV. Proc Natl Acad Sci USA 1998;95:1207-12
   PubMed Web of Science ®Google Scholar
• Acham-Roschitz B, Plecko B, Lindbichler F, A novel mutation of the RRM2B gene in an infant with early fatal encephalomyopathy, central hypomyelination, and tubulopathy. Mol Genet Metab 2009;98:300-4
   PubMed Web of Science ®Google Scholar
• Dabbagh O, Swaiman KF. Cockayne syndrome: MRI correlates of hypomyelination. Pediatr Neurol 1988;4:113-16
   PubMed Web of Science ®Google Scholar
• van der Knaap MS, Barth PG, Stroink H, Leukoencephalopathy with swelling and a discrepantly mild clinical course in eight children. Ann Neurol 1995;37:324-34
   PubMed Web of Science ®Google Scholar
• Bizzi A, Castelli G, Bugiani M, Classification of childhood white matter disorders using proton MR spectroscopic imaging. AJNR Am J Neuroradiol 2008;29:1270-5
   PubMed Web of Science ®Google Scholar
• van der Voorn JP, Pouwels PJ, Hart AA, Childhood white matter disorders: quantitative MR imaging and spectroscopy. Radiology 2006;241:510-17
   PubMed Web of Science ®Google Scholar
• Lin DD, Crawford TO, Barker PB. Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease. AJNR Am J Neuroradiol 2003;24:33-41
   PubMed Web of Science ®Google Scholar
• Varho T, Komu M, Sonninen P, A new metabolite contributing to N-acetyl signal in 1H MRS of the brain in Salla disease. Neurology 1999;52:1668-72
   PubMed Web of Science ®Google Scholar
• Cakmakci H, Pekcevik Y, Yis U, Diagnostic value of proton MR spectroscopy and diffusion-weighted MR imaging in childhood inherited neurometabolic brain diseases and review of the literature. Eur J Radiol 2010;74:e161-71
   PubMedGoogle Scholar
• Bugiani M, Lamantea E, Invernizzi F, Effects of riboflavin in children with complex II deficiency. Brain Dev 2006;28:576-81
   PubMed Web of Science ®Google Scholar
• Stockler S, Holzbach U, Hanefeld F, Creatine deficiency in the brain: a new, treatable inborn error of metabolism. Pediatr Res 1994;36:409-13
   PubMed Web of Science ®Google Scholar
• Labrune P, Lacroix C, Goutieres F, Extensive brain calcifications, leukodystrophy, and formation of parenchymal cysts: a new progressive disorder due to diffuse cerebral microangiopathy. Neurology 1996;46:1297-301
   PubMed Web of Science ®Google Scholar
• Nagae-Poetscher LM, Bibat G, Philippart M, Leukoencephalopathy, cerebral calcifications, and cysts: new observations. Neurology 2004;62:1206-9
   PubMed Web of Science ®Google Scholar
• Anderson BH, Kasher PR, Mayer J. Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus. Nat Genet 2012; Epub ahead of print
   Web of Science ®Google Scholar
• Rice G, Patrick T, Parmar R, Clinical and molecular phenotype of Aicardi-Goutieres syndrome. Am J Hum Genet 2007;81:713-25
   PubMed Web of Science ®Google Scholar
• Goutieres F, Aicardi J, Barth PG, Lebon P. Aicardi-Goutieres syndrome: an update and results of interferon-alpha studies. Ann Neurol 1998;44:900-7
   PubMed Web of Science ®Google Scholar
• Livingston JH, Graziano C, Pysden K, Intracranial calcification in early infantile Krabbe disease: nothing new under the sun. Dev Med Child Neurol 2011; Epub ahead of print
   Web of Science ®Google Scholar
• Rajab A, Aldinger KA, El-Shirbini HA, Recessive developmental delay, small stature, microcephaly and brain calcifications with locus on chromosome 2. Am J Med Genet A 2009;149A:129-37
   PubMed Web of Science ®Google Scholar
• Lopez-Hernandez T, Sirisi S, Capdevila-Nortes X, Molecular mechanisms of MLC1 and GLIALCAM mutations in megalencephalic leukoencephalopathy with subcortical cysts. Hum Mol Genet 2011;20(16):3266-77
   PubMed Web of Science ®Google Scholar
• Lopez-Hernandez T, Ridder MC, Montolio M, Mutant GlialCAM causes megalencephalic leukoencephalopathy with subcortical cysts, benign familial macrocephaly, and macrocephaly with retardation and autism. Am J Hum Genet 2011;88(4):422-32
   PubMed Web of Science ®Google Scholar
• Prashanth LK, Sinha S, Taly AB, Spectrum of epilepsy in Wilson's disease with electroencephalographic, MR imaging and pathological correlates. J Neurol Sci 2010;291:44-51
   PubMed Web of Science ®Google Scholar
• Sankhyan N, Sharma S, Kalra V, Cystic white-matter changes in childhood Wilson's disease. Pediatr Neurol 2008;39:281-2
   PubMed Web of Science ®Google Scholar
• Sinha S, Taly AB, Ravishankar S, Wilson's disease: cranial MRI observations and clinical correlation. Neuroradiology 2006;48:613-21
   PubMed Web of Science ®Google Scholar
• Taly AB, Prashanth LK, Sinha S. Wilson's disease: an Indian perspective. Neurol India 2009;57:528-40
   PubMed Web of Science ®Google Scholar
• Wolf NI, Seitz A, Harting I, New pattern of brain MRI lesions in isolated complex I deficiency. Neuropediatrics 2003;34:156-9
   PubMed Web of Science ®Google Scholar
• Schuelke M, Smeitink J, Mariman E, Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy. Nat Genet 1999;21:260-1
   PubMed Web of Science ®Google Scholar
• Zafeiriou DI, Rodenburg RJ, Scheffer H, MR spectroscopy and serial magnetic resonance imaging in a patient with mitochondrial cystic leukoencephalopathy due to complex I deficiency and NDUFV1 mutations and mild clinical course. Neuropediatrics 2008;39:172-5
   PubMed Web of Science ®Google Scholar
• Ferreira M, Torraco A, Rizza T, Progressive cavitating leukoencephalopathy associated with respiratory chain complex I deficiency and a novel mutation in NDUFS1. Neurogenetics 2011;12(1):9-17
   PubMed Web of Science ®Google Scholar
• Brockmann K, Bjornstad A, Dechent P, Succinate in dystrophic white matter: a proton magnetic resonance spectroscopy finding characteristic for complex II deficiency. Ann Neurol 2002;52:38-46
   PubMed Web of Science ®Google Scholar
• Topcu M, Saatci I, Apak RA, Leigh syndrome in a 3-year-old boy with unusual brain MR imaging and pathologic findings. AJNR Am J Neuroradiol 2000;21:224-7
   PubMed Web of Science ®Google Scholar
• Dreha-Kulaczewski SF, Dechent P, Finsterbusch J, Early reduction of total N-acetyl-aspartate-compounds in patients with classical vanishing white matter disease. A long-term follow-up MRS study. Pediatr Res 2008;63:444-9
   PubMed Web of Science ®Google Scholar
• Vissers LE, de LJ, Gilissen C, A de novo paradigm for mental retardation. Nat Genet 2010;42:1109-12
   PubMed Web of Science ®Google Scholar
• Harding CO. New era in treatment for phenylketonuria: pharmacologic therapy with sapropterin dihydrochloride. Biologics 2010;4:231-6
   PubMedGoogle Scholar
• Orchard PJ, Tolar J. Transplant outcomes in leukodystrophies. Semin Hematol 2010;47:70-8
   PubMed Web of Science ®Google Scholar
• Sauer M, Grewal S, Peters C. Hematopoietic stem cell transplantation for mucopolysaccharidoses and leukodystrophies. Klin Padiatr 2004;216:163-8
   PubMed Web of Science ®Google Scholar
• Cartier N, Hacein-Bey-Abina S, Von KC, Gene therapy of x-linked adrenoleukodystrophy using hematopoietic stem cells and a lentiviral vector. Bull Acad Natl Med 2010;194:255-64
   PubMed Web of Science ®Google Scholar